$1.55 Billion is the total value of Nantahala Capital Management's 120 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 37.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Sell | ISHARES TRput | $187,184,000 | -55.8% | 1,135,000 | -54.6% | 12.11% | -42.9% |
| IWM | New | ISHARES TRcall | $131,936,000 | – | 800,000 | +100.0% | 8.54% | – |
| ESTA | Sell | ESTABLISHMENT LABS HLDGS INC | $102,909,000 | -5.7% | 1,884,430 | -6.1% | 6.66% | +21.7% |
| TA | Sell | TRAVELCENTERS OF AMERICA INC | $59,172,000 | +34.9% | 1,097,201 | -13.8% | 3.83% | +74.0% |
| QURE | Sell | UNIQURE NV | $54,440,000 | -5.5% | 2,901,929 | -6.1% | 3.52% | +21.9% |
| CASH | Buy | PATHWARD FINANCIAL INC | $43,770,000 | +14.9% | 1,327,968 | +34.8% | 2.83% | +48.2% |
| COST | Sell | COSTCO WHSL CORP NEWput | $43,071,000 | -10.1% | 91,200 | -8.8% | 2.79% | +16.0% |
| COST | Buy | COSTCO WHSL CORP NEW | $40,917,000 | +19.4% | 86,640 | +21.2% | 2.65% | +54.1% |
| IMAX | Sell | IMAX CORP | $38,171,000 | -17.2% | 2,703,336 | -1.0% | 2.47% | +6.8% |
| LXFR | Buy | LUXFER HLDGS PLC | $33,895,000 | -3.7% | 2,337,605 | +0.4% | 2.19% | +24.2% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $33,052,000 | -35.5% | 1,375,428 | -48.4% | 2.14% | -16.7% |
| KROS | Sell | KEROS THERAPEUTICS INC | $31,815,000 | +26.3% | 845,692 | -7.3% | 2.06% | +63.0% |
| TNL | Sell | TRAVEL PLUS LEISURE CO | $31,606,000 | -16.5% | 926,313 | -5.0% | 2.04% | +7.7% |
| TNL | TRAVEL PLUS LEISURE COcall | $31,360,000 | -12.1% | 919,100 | 0.0% | 2.03% | +13.4% | |
| IMAX | IMAX CORPcall | $30,941,000 | -16.4% | 2,191,300 | 0.0% | 2.00% | +7.9% | |
| SGMS | Sell | LIGHT & WONDER INC | $29,808,000 | -42.9% | 695,155 | -37.4% | 1.93% | -26.3% |
| DXPE | Sell | DXP ENTERPRISES INC | $27,499,000 | -25.5% | 1,161,280 | -3.6% | 1.78% | -3.8% |
| CDXS | Buy | CODEXIS INC | $27,294,000 | -36.7% | 4,504,009 | +9.3% | 1.77% | -18.3% |
| IMTX | Sell | IMMATICS N.V | $27,140,000 | -0.2% | 2,713,968 | -13.1% | 1.76% | +28.7% |
| DRI | DARDEN RESTAURANTS INCput | $25,264,000 | +11.7% | 200,000 | 0.0% | 1.64% | +44.2% | |
| MLHR | Sell | MILLERKNOLL INC | $24,370,000 | -45.7% | 1,562,174 | -8.5% | 1.58% | -29.9% |
| RDVT | Sell | RED VIOLET INC | $22,157,000 | -9.9% | 1,279,254 | -1.0% | 1.43% | +16.3% |
| DHX | Sell | DHI GROUP INC | $22,014,000 | +7.0% | 4,091,744 | -1.1% | 1.42% | +38.2% |
| APEN | Buy | APOLLO ENDOSURGERY INC | $21,896,000 | +61.1% | 3,973,906 | +6.7% | 1.42% | +108.1% |
| RMR | Sell | RMR GROUP INCcl a | $21,589,000 | -21.5% | 911,305 | -6.1% | 1.40% | +1.2% |
| QURE | Buy | UNIQURE NVcall | $18,760,000 | +25.8% | 1,000,000 | +25.0% | 1.21% | +62.3% |
| PAYA | Sell | PAYA HOLDINGS INC | $17,947,000 | -7.7% | 2,937,353 | -0.8% | 1.16% | +19.1% |
| HLF | HERBALIFE NUTRITION LTDcall | $17,259,000 | -2.7% | 867,700 | 0.0% | 1.12% | +25.5% | |
| GDEN | Sell | GOLDEN ENTMT INC | $16,816,000 | -12.3% | 481,965 | -0.6% | 1.09% | +13.1% |
| PTON | Sell | PELOTON INTERACTIVE INC | $16,052,000 | -28.6% | 2,316,342 | -5.4% | 1.04% | -7.8% |
| ALTG | Sell | ALTA EQUIPMENT GROUP INC | $14,472,000 | -3.5% | 1,314,421 | -21.4% | 0.94% | +24.6% |
| RH | Sell | RH | $13,698,000 | -28.3% | 55,669 | -38.1% | 0.89% | -7.5% |
| MAX | Sell | MEDIAALPHA INCcl a | $13,637,000 | -15.6% | 1,558,508 | -5.0% | 0.88% | +9.0% |
| IWM | Buy | ISHARES TRrussell 2000 etf | $12,430,000 | +207.4% | 75,370 | +215.7% | 0.80% | +296.1% |
| CNCE | Buy | CONCERT PHARMACEUTICALS INC | $11,974,000 | +71.4% | 1,787,159 | +7.7% | 0.78% | +121.4% |
| LYRA | Sell | LYRA THERAPEUTICS INC | $11,252,000 | -16.0% | 2,245,830 | -5.2% | 0.73% | +8.5% |
| AUTL | Buy | AUTOLUS THERAPEUTICS PLCspon ads | $11,162,000 | -23.3% | 5,215,788 | +1.4% | 0.72% | -1.1% |
| APEN | Buy | APOLLO ENDOSURGERY INCcall | $11,020,000 | +88.7% | 2,000,000 | +25.0% | 0.71% | +143.3% |
| VMD | Buy | VIEMED HEALTHCARE INC | $10,743,000 | +16.4% | 1,790,505 | +4.4% | 0.70% | +50.1% |
| Buy | DARIOHEALTH CORP | $10,165,000 | -4.3% | 2,195,373 | +26.8% | 0.66% | +23.5% | |
| AMYT | Sell | AMRYT PHARMA PLCsponsored ads | $9,947,000 | -8.9% | 1,437,458 | -8.0% | 0.64% | +17.5% |
| RH | New | RHcall | $9,843,000 | – | 40,000 | +100.0% | 0.64% | – |
| RDI | Sell | READING INTL INCcl a | $9,596,000 | -17.1% | 2,916,575 | -9.1% | 0.62% | +6.9% |
| PTON | Buy | PELOTON INTERACTIVE INCcall | $9,484,000 | -9.3% | 1,368,600 | +20.2% | 0.61% | +17.2% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $8,661,000 | +11.0% | 2,474,659 | -6.4% | 0.56% | +43.2% |
| Sell | ARYA SCIENCES ACQUISITN CORP | $7,478,000 | -10.8% | 759,572 | -11.9% | 0.48% | +15.2% | |
| Sell | AKUMIN INC | $7,277,000 | +118.9% | 4,255,572 | -23.3% | 0.47% | +182.0% | |
| FBIO | Sell | FORTRESS BIOTECH INC | $7,106,000 | -3.4% | 8,263,052 | -5.7% | 0.46% | +24.7% |
| Buy | AURA BIOSCIENCES INC | $6,954,000 | +43.0% | 383,764 | +11.8% | 0.45% | +84.4% | |
| RNG | Buy | RINGCENTRAL INCcl a | $6,698,000 | -14.6% | 167,622 | +11.7% | 0.43% | +10.2% |
| SBTX | Sell | SILVERBACK THERAPEUTICS INC | $6,599,000 | +12.3% | 1,249,863 | -9.8% | 0.43% | +44.7% |
| PRDO | PERDOCEO ED CORPput | $5,150,000 | -12.6% | 500,000 | 0.0% | 0.33% | +12.9% | |
| ONTF | Sell | ON24 INC | $4,742,000 | -12.4% | 538,906 | -5.5% | 0.31% | +13.3% |
| Sell | APTOSE BIOSCIENCES INC | $4,099,000 | -23.6% | 6,888,822 | -4.8% | 0.26% | -1.5% | |
| New | VENTYX BIOSCIENCES INC | $4,072,000 | – | 116,633 | +100.0% | 0.26% | – | |
| RMBL | Buy | RUMBLEON INC | $4,010,000 | +36.3% | 236,975 | +18.5% | 0.26% | +75.7% |
| SSKN | Sell | STRATA SKIN SCIENCES INC | $3,827,000 | -13.0% | 4,393,685 | -4.0% | 0.25% | +12.7% |
| IDYA | New | IDEAYA BIOSCIENCES INC | $3,782,000 | – | 253,480 | +100.0% | 0.24% | – |
| Sell | PAR TECHNOLOGY CORPnote 2.875% 4/1 | $3,759,000 | -43.7% | 3,785,000 | -34.6% | 0.24% | -27.5% | |
| TSHA | Sell | TAYSHA GENE THERAPIES INC | $3,246,000 | -46.9% | 1,610,822 | -2.0% | 0.21% | -31.6% |
| PWP | Buy | PERELLA WEINBERG PARTNERS | $3,199,000 | +9.1% | 505,293 | +0.5% | 0.21% | +40.8% |
| RILY | Sell | B. RILEY FINANCIAL INC | $3,041,000 | -6.6% | 68,296 | -11.4% | 0.20% | +20.9% |
| TELA | New | TELA BIO INC | $2,973,000 | – | 349,002 | +100.0% | 0.19% | – |
| CDTX | Sell | CIDARA THERAPEUTICS INC | $2,924,000 | +24.2% | 4,559,201 | -5.4% | 0.19% | +60.2% |
| ARYD | Sell | ARYA SCIENCES ACQU CORP IVcl a | $2,833,000 | -10.6% | 285,730 | -11.5% | 0.18% | +15.1% |
| SMLR | Sell | SEMLER SCIENTIFIC INC | $2,719,000 | -72.2% | 72,397 | -79.1% | 0.18% | -64.1% |
| IMTXW | Sell | IMMATICS N.V*w exp 07/01/202 | $2,676,000 | +26.6% | 987,432 | -4.7% | 0.17% | +63.2% |
| BVS | New | BIOVENTUS INC | $2,652,000 | – | 378,839 | +100.0% | 0.17% | – |
| CRIS | Sell | CURIS INC | $2,434,000 | -31.9% | 3,420,510 | -5.7% | 0.16% | -11.7% |
| TCDA | New | TRICIDA INC | $2,406,000 | – | 229,610 | +100.0% | 0.16% | – |
| SRL | Sell | SCULLY ROYALTY LTD | $2,357,000 | -61.9% | 318,493 | -58.7% | 0.15% | -50.6% |
| PAYO | PAYONEER GLOBAL INC | $2,331,000 | +54.3% | 385,366 | 0.0% | 0.15% | +98.7% | |
| AAN | New | THE AARONS COMPANY INC | $1,958,000 | – | 201,467 | +100.0% | 0.13% | – |
| RZLT | New | REZOLUTE INC | $1,969,000 | – | 718,736 | +100.0% | 0.13% | – |
| AGLE | Sell | AEGLEA BIOTHERAPEUTICS INC | $1,952,000 | -0.3% | 3,710,778 | -4.3% | 0.13% | +28.6% |
| New | AVALO THERAPEUTICS INC | $1,819,000 | – | 547,814 | +100.0% | 0.12% | – | |
| VRM | VROOM INCcall | $1,740,000 | -7.2% | 1,500,000 | 0.0% | 0.11% | +20.2% | |
| NPCE | Sell | NEUROPACE INC | $1,663,000 | -29.8% | 443,502 | -7.3% | 0.11% | -9.2% |
| MACK | Sell | MERRIMACK PHARMACEUTICALS IN | $1,611,000 | -44.9% | 429,596 | -12.6% | 0.10% | -29.3% |
| IDWM | Sell | IDW MEDIA HLDGS INCcl b | $1,601,000 | +13.5% | 1,039,830 | -1.2% | 0.10% | +46.5% |
| KROS | KEROS THERAPEUTICS INCcall | $1,576,000 | +36.1% | 41,900 | 0.0% | 0.10% | +75.9% | |
| PNT | New | POINT BIOPHARMA GLOBAL INC | $1,529,000 | – | 197,783 | +100.0% | 0.10% | – |
| ANEB | New | ANEBULO PHARMACEUTICALS INC | $1,431,000 | – | 511,073 | +100.0% | 0.09% | – |
| NAUT | Sell | NAUTILUS BIOTECHNOLOGY INC | $1,389,000 | -34.2% | 655,338 | -16.5% | 0.09% | -15.1% |
| CBIO | Sell | CATALYST BIOSCIENCES INC | $1,288,000 | -73.7% | 2,554,735 | -7.3% | 0.08% | -66.3% |
| STIM | Sell | NEURONETICS INC | $1,209,000 | -50.9% | 380,325 | -50.4% | 0.08% | -37.1% |
| AGS | New | PLAYAGS INC | $1,179,000 | – | 222,518 | +100.0% | 0.08% | – |
| New | SOLENO THERAPEUTICS INC | $1,009,000 | – | 604,179 | +100.0% | 0.06% | – | |
| ANGN | Sell | ANGION BIOMEDICA CORP | $981,000 | -23.9% | 1,066,012 | -5.7% | 0.06% | -3.1% |
| ACER | Sell | ACER THERAPEUTICS INC | $968,000 | +3.6% | 696,538 | -6.0% | 0.06% | +34.0% |
| LQDA | New | LIQUIDIA CORPORATION | $799,000 | – | 146,792 | +100.0% | 0.05% | – |
| ALEC | Sell | ALECTOR INC | $809,000 | -13.7% | 85,514 | -7.2% | 0.05% | +10.6% |
| HELIOGEN INC | $807,000 | -11.9% | 433,909 | 0.0% | 0.05% | +13.0% | ||
| SGRP | New | SPAR GROUP INC | $781,000 | – | 538,427 | +100.0% | 0.05% | – |
| SNDX | New | SYNDAX PHARMACEUTICALS INCcall | $721,000 | – | 30,000 | +100.0% | 0.05% | – |
| IMAC | Sell | IMAC HLDGS INC | $466,000 | -55.4% | 1,229,665 | -2.4% | 0.03% | -42.3% |
| HYPERFINE INC | $448,000 | -63.1% | 544,930 | 0.0% | 0.03% | -52.5% | ||
| Sell | LUCID DIAGNOSTICS INC | $438,000 | -37.2% | 286,432 | -7.3% | 0.03% | -20.0% | |
| GMTX | New | GEMINI THERAPEUTICS INC | $423,000 | – | 257,672 | +100.0% | 0.03% | – |
| Sell | UNICYCIVE THERAPEUTICS INC | $419,000 | -30.9% | 710,542 | -2.6% | 0.03% | -10.0% | |
| XGN | Sell | EXAGEN INC | $408,000 | -54.5% | 150,535 | -3.6% | 0.03% | -42.2% |
| CDXS | CODEXIS INCcall | $303,000 | -42.1% | 50,000 | 0.0% | 0.02% | -23.1% | |
| IDN | New | INTELLICHECK INC | $314,000 | – | 124,594 | +100.0% | 0.02% | – |
| ZVO | Buy | ZOVIO INC | $281,000 | -82.5% | 1,961,635 | +18.5% | 0.02% | -77.8% |
| TACT | Sell | TRANSACT TECHNOLOGIES INC | $240,000 | -14.0% | 65,738 | -6.1% | 0.02% | +14.3% |
| CUE | Sell | CUE BIOPHARMA INC | $208,000 | -16.8% | 93,297 | -7.1% | 0.01% | 0.0% |
| AUTL | New | AUTOLUS THERAPEUTICS PLCcall | $150,000 | – | 70,300 | +100.0% | 0.01% | – |
| New | CYREN LTD | $139,000 | – | 141,615 | +100.0% | 0.01% | – | |
| SFT | Sell | SHIFT TECHNOLOGIES INCcl a | $140,000 | -92.2% | 200,000 | -92.5% | 0.01% | -90.0% |
| RFL | Buy | RAFAEL HLDGS INC | $131,000 | +263.9% | 72,678 | +274.0% | 0.01% | +300.0% |
| Sell | WEJO GROUP LIMITED | $129,000 | -18.4% | 118,175 | -11.0% | 0.01% | 0.0% | |
| SITIO ROYALTIES CORP*w exp 08/23/202 | $99,000 | +6.5% | 582,350 | 0.0% | 0.01% | +20.0% | ||
| KTRA | Buy | KINTARA THERAPEUTICS INC | $64,000 | +100.0% | 594,813 | +411.7% | 0.00% | +100.0% |
| TC BIOPHARM HOLDINGS PLC*w exp 02/08/202 | $29,000 | -48.2% | 235,294 | 0.0% | 0.00% | -33.3% | ||
| QUALTEK SERVICES INC*w exp 02/14/202 | $26,000 | +73.3% | 96,244 | 0.0% | 0.00% | +100.0% | ||
| FTCVW | FINTECH ACQUISITION CORP V*w exp 12/31/202 | $13,000 | -56.7% | 333,331 | 0.0% | 0.00% | -50.0% | |
| IIIIW | INSU ACQUISITION CORP III*w exp 12/31/202 | $23,000 | -23.3% | 333,332 | 0.0% | 0.00% | -50.0% | |
| FINTECH ACQUISITION CORP VI*w exp 03/31/202 | $10,000 | -74.4% | 240,600 | 0.0% | 0.00% | -50.0% | ||
| HERAW | FTAC HERA ACQUISITION CORP*w exp 02/28/202 | $19,000 | -64.2% | 222,949 | 0.0% | 0.00% | -66.7% | |
| GUARDFORCE AI CO LTD*w exp 10/01/202 | $22,000 | +15.8% | 154,205 | 0.0% | 0.00% | 0.0% | ||
| MILEW | Exit | METROMILE INC*w exp 02/09/202 | $0 | – | -507,460 | -100.0% | -0.00% | – |
| BRPMW | Exit | B RILEY PRINCIPAL 150 MERGER*w exp 03/01/202 | $0 | – | -185,653 | -100.0% | -0.00% | – |
| PWPPW | Exit | PERELLA WEINBERG PARTNERS*w exp 12/31/202 | $0 | – | -409,128 | -100.0% | -0.01% | – |
| MILE | Exit | METROMILE INC | $0 | – | -325,002 | -100.0% | -0.02% | – |
| Exit | IN8BIO INC | $0 | – | -148,801 | -100.0% | -0.02% | – | |
| Exit | COGNITION THERAPEUTICS INC | $0 | – | -192,752 | -100.0% | -0.02% | – | |
| EAR | Exit | EARGO INC | $0 | – | -1,028,965 | -100.0% | -0.04% | – |
| Exit | FARADAY FUTRE INTLGT ELCTR I | $0 | – | -350,000 | -100.0% | -0.05% | – | |
| IMV | Exit | IMV INC | $0 | – | -1,424,676 | -100.0% | -0.05% | – |
| LVTX | Exit | LAVA THERAPEUTICS NV | $0 | – | -322,980 | -100.0% | -0.05% | – |
| FVAM | Exit | 5 01 ACQUISITION CORP | $0 | – | -157,044 | -100.0% | -0.08% | – |
| SLNO | Exit | SOLENO THERAPEUTICS INC | $0 | – | -9,436,512 | -100.0% | -0.08% | – |
| KR | Exit | KROGER COcall | $0 | – | -50,000 | -100.0% | -0.12% | – |
| BRPM | Exit | B RILEY PRINCIPAL 150 MERGER | $0 | – | -297,727 | -100.0% | -0.15% | – |
| Exit | AVALO THERAPEUTICS INC | $0 | – | -6,710,327 | -100.0% | -0.17% | – | |
| INMD | Exit | INMODE LTD | $0 | – | -158,154 | -100.0% | -0.18% | – |
| SYK | Exit | STRYKER CORPORATION | $0 | – | -23,000 | -100.0% | -0.23% | – |
| HERA | Exit | FTAC HERA ACQUISITION CORP | $0 | – | -787,130 | -100.0% | -0.39% | – |
| GOGO | Exit | GOGO INCput | $0 | – | -500,000 | -100.0% | -0.41% | – |
| IIII | Exit | INSU ACQUISITION CORP III | $0 | – | -980,183 | -100.0% | -0.48% | – |
| BBQ | Exit | BBQ HLDGS INC | $0 | – | -948,254 | -100.0% | -0.50% | – |
| SYK | Exit | STRYKER CORPORATIONput | $0 | – | -120,000 | -100.0% | -1.20% | – |
| ATGE | Exit | ADTALEM GLOBAL ED INCput | $0 | – | -900,000 | -100.0% | -1.62% | – |
| AMPH | Exit | AMPHASTAR PHARMACEUTICALS INput | $0 | – | -1,000,000 | -100.0% | -1.74% | – |
| LLY | Exit | LILLY ELI & COput | $0 | – | -350,000 | -100.0% | -5.69% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-10
About Nantahala Capital Management
Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.
Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.
Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.
Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 40 | Q1 2023 | 27.2% |
| CODEXIS INC | 40 | Q1 2023 | 3.9% |
| SCIENTIFIC GAMES CORP | 34 | Q3 2022 | 5.3% |
| DOVER MOTORSPORTS INC | 34 | Q3 2021 | 0.5% |
| PATHWARD FINANCIAL INC | 33 | Q1 2023 | 4.3% |
| QAD INC | 32 | Q3 2021 | 2.6% |
| SCIENTIFIC GAMES CORP | 31 | Q4 2021 | 7.7% |
| DOLBY LABORATORIES INC | 31 | Q4 2020 | 5.6% |
| GOLDEN ENTMT INC | 31 | Q1 2023 | 2.1% |
| LINCOLN EDL SVCS CORP | 31 | Q4 2021 | 0.7% |
View Nantahala Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. | February 14, 2023 | 1,359,687 | 7.9% |
| Acer Therapeutics Inc. | February 14, 2023 | 1,226,191 | 7.5% |
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 4,611,302 | 7.5% |
| AKUMIN INC. | February 14, 2023 | 2,206,960 | 2.5% |
| ALTA EQUIPMENT GROUP INC. | February 14, 2023 | 1,188,985 | 3.7% |
| Apollo Endosurgery, Inc. | February 14, 2023 | 4,056,627 | 9.9% |
| Aptose Biosciences Inc. | February 14, 2023 | 6,052,867 | 6.6% |
| Autolus Therapeutics plc | February 14, 2023 | 7,782,018 | 4.7% |
| Avalo Therapeutics, Inc. | February 14, 2023 | 654,674 | 7.0% |
| Bioventus Inc. | February 14, 2023 | 3,168,574 | 5.1% |
View Nantahala Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D | 2023-05-26 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
View Nantahala Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.